Last update:

Alzheimer's disease & dementia news

Medical research

Dietary compound increases longevity and protects against Alzheimer's disease in experimental models

Researchers from the Color and Food Quality group at the Faculty of Pharmacy (University of Seville), in collaboration with Dr. Marina Ezcurra's group at the University of Kent (U.K.), have shown that the carotenoid phytoene ...

Alzheimer's disease & dementia

Questions over safety and effectiveness of new Alzheimer's drug

The safety and effectiveness of donanemab—an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA)—is called into question in an investigation published by The BMJ.

Genetics

Master copper regulator discovery may offer Alzheimer's clues

New therapeutic opportunities often emerge from research on simple organisms. For instance, the 2020 Nobel Prize in Chemistry awarded to Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., for their CRISPR-based DNA ...

Alzheimer's disease & dementia

Boosting brain protein levels may slow decline from Alzheimer's

A study published in the journal Brain shows that increases in protein levels with new Alzheimer's drugs can explain the slowing of cognitive impairment at least as well as the reduction in amyloid plaques.

Alzheimer's disease & dementia

Biological clock disruptions sound Alzheimer's alarm

New Alzheimer's research from UVA Health suggests that enhanced light sensitivity may contribute to "sundowning"—the worsening of the disease's symptoms late in the day—and spur sleep disruptions thought to contribute ...

Alzheimer's disease & dementia

Blood-based biomarkers for Alzheimer's disease: Study in China

Discrepancies in diagnostic biomarkers for Alzheimer's Disease (AD) may arise from racial disparities, risk factors, or lifestyle differences. Moreover, there has been a lack of systematic and multicenter studies to evaluate ...

Genetics

Researching twins to better understand memory decline

As people age, they often worry about declining memory and other cognitive abilities. Many of them will see a doctor, who may do some tests to find out that they are functioning normally. This is generally referred to as ...

Neuroscience

Guidance on new treatments for early Alzheimer's disease issued

New therapies for early Alzheimer's disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing hope to people whose lives have been affected by the disease. To help neurologists discuss these ...

Alzheimer's disease & dementia

Older women at risk for Alzheimer's disease may benefit from yoga

Kundalini yoga, a form of yoga that focuses on breathing, meditation, and mental visualization, appeared beneficial for older women who had risk factors for Alzheimer's disease and concerns about episodes of memory decline, ...

Health

Probiotics are good for more than your gut

Many people turn to probiotics for their digestive woes, but a preliminary study suggests that what's good for gut may also be good for the aging brain.

Genetics

Scientists spot 32 proteins that hint at Alzheimer's risk

It's difficult to fully predict who will develop Alzheimer's disease in advance. Now, a new study suggests that certain markers in the blood may occur 10 to 20 years before the start of symptoms and could help doctors determine ...

Genetics

Alzheimer's genetic risk tracked across sex, race

A new study of genetic risks for cognitive impairment later in life uses data from 32,426 research participants aged 60 and older to elaborate risk across sex and across the intersection of sex and race. The study, the largest ...

Genetics

Potential new biomarker for Alzheimer's discovered

Alzheimer's is considered a disease of old age, with most people being diagnosed after 65. But the condition actually begins developing, out of sight, many years before any symptoms emerge. Tiny proteins, known as amyloid-beta ...